Clinical Trial Update: A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing clopidogrel monotherapy to extended dual antiplatelet therapy beyond 12 months after drug-eluting stent implantation i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease, DES | Phase 4 | Status: ACTIVE_NOT_RECRUITING